A rating of 31 puts Meridian Bioscience, Inc. (VIVO) near the bottom of the Diagnostics & Research industry according to InvestorsObserver. Meridian Bioscience, Inc.'s score of 31 means it scores higher than 31% of stocks in the industry. Meridian Bioscience, Inc. also received an overall rating of 33, putting it above 33% of all stocks. Diagnostics & Research is ranked 69 out of the 148 industries.
VIVO has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VIVO!